Patent classifications
C07D419/12
Insecticidal compounds based on isoxazoline derivatives
The present invention relates to compounds of formula (I): ##STR00001##
wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, G.sup.1, L, Y.sup.1, Y.sup.2, Y.sup.3, Y.sup.4, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to intermediates for preparing compounds of formula (I), to compositions comprising them and to methods of using them to combat and control insect, acarine, nematode and mollusc pests.
Insecticidal compounds based on isoxazoline derivatives
The present invention relates to compounds of formula (I): ##STR00001##
wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, G.sup.1, L, Y.sup.1, Y.sup.2, Y.sup.3, Y.sup.4, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to intermediates for preparing compounds of formula (I), to compositions comprising them and to methods of using them to combat and control insect, acarine, nematode and mollusc pests.
ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS
The present invention relates to ether-linked triazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof:
##STR00001##
ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS
The present invention relates to ether-linked triazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof:
##STR00001##
COVALENT INHIBITORS OF KRAS G12C
Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.
COVALENT INHIBITORS OF KRAS G12C
Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.
Compound for organic electric element, organic electric element using the same, and electronic device thereof
Provided is a novel compound capable of improving the luminous efficiency, stability and life span of a device, an organic electric element using the same, and an electronic device thereof.
2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use
Described herein are alkylated imino sugars derivatives having a disease-modifying action in the treatment of diseases associated with glucosidase activity that include viral hemorrhagic fevers and other enveloped viruses, and any other diseases involving glucosidase activity.
2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use
Described herein are alkylated imino sugars derivatives having a disease-modifying action in the treatment of diseases associated with glucosidase activity that include viral hemorrhagic fevers and other enveloped viruses, and any other diseases involving glucosidase activity.
INSECTICIDAL COMPOUNDS BASED ON ISOXAZOLINE DERIVATIVES
The present invention relates to compounds of formula (I):
##STR00001##
wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, G.sup.1, L, Y.sup.1, Y.sup.2, Y.sup.3, Y.sup.4, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in claim 1; or a salt or N-oxide thereof.
Furthermore, the present invention relates to intermediates for preparing compounds of formula (I), to compositions comprising them and to methods of using them to combat and control insect, acarine, nematode and mollusc pests.